Clinical Trials Browser

Phase 2 × Mouth Neoplasms × Observation × Clear all

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts

Mouth Neoplasms

NCT06728631 2025-02-24

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Phase 2 Active not recruiting

Mouth Neoplasms